Tradestie Institutional Equity Comparison Engine

ABVE vs HLF โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HLF Overall Edge

HLF Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Herbalife Ltd. (HLF) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ABVE trades at N/M Forward P/E with -23.2% operating margin (-45.0% YoY revenue) versus HLF at 5.3x Forward P/E and 9.8% operating margin (+6.0% YoY). In options structure, ABVE sits in UNCLASSIFIED (8th %ile IV; Dealer Gamma Walls on Pro) against HLF sits in SURGE (8th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner HLF
ABVE N/M vs HLF 5.3x Fwd P/E
Growth & Margin Winner HLF
Op Margin -23.2% vs 9.8% ยท YoY -45.0% vs +6.0%
Momentum & Technical Winner HLF
1Y -90.2% vs +68.9% ยท 52W Pos 0% vs 62%
Options & Structure Winner HLF
UNCLASSIFIED (8th %ile IV) vs SURGE (8th %ile IV)
ABVE NASDAQ
Above Food Ingredients Inc. Common Stock
Food And Kindred Products
$0.11
-80.57% 1D
Market Cap $30.0M
1M Return -79.18%
1Y Return -90.17%
Forward P/E N/M
Unified AI Score
39.8 / 100 SELL
Tech 40.0 Fund 47.0 Flow 57.0 Mom 40.0
HLF NYSE
Herbalife Ltd.
Wholesale-Drugs, Proprietaries & Druggists' Sundries
$15.93
-0.19% 1D
Market Cap $1.6B
1M Return +9.11%
1Y Return +68.93%
Forward P/E 5.3x
Unified AI Score
35.2 / 100 SELL
Tech 50.0 Fund 31.0 Flow 59.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABVE -90.17% HLF +68.93% Spread: +120.57 pp (HLF Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABVE TTM Op. Margin: -23.2% HLF TTM Op. Margin: 9.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVE vs HLF. Trailing 12-month operating profitability (ABVE -23.2% vs HLF 9.8%) and valuation multiples (ABVE N/M vs HLF 5.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABVE (1) vs HLF (8)
Institutional Metric ABVE HLF Criterion Row Winner
Market Capitalization Scale $30.0M $1.6B Larger Scale HLF
Trailing P/E Ratio Valuation N/M 8.9x Lower Multiple HLF
Forward P/E Ratio Valuation N/M 5.3x Lower Multiple HLF
Revenue Growth (YoY) Growth -45.0% +6.0% Higher Growth HLF
Operating Margin (TTM) Profitability -23.2% 9.8% Higher Margin HLF
Net Profit Margin Profitability -23.4% 3.4% Higher Margin HLF
Return on Equity (ROE) Capital Efficiency 0.0% 0.0% Higher ROE Tie
52-Week Range Position Momentum 0% ($0โ€“$7) 62% ($9โ€“$20) Stronger Trend HLF
Beta / 30D Volatility Risk Regime 4.10ฮฒ ยท 310% Vol 1.08ฮฒ ยท 48% Vol Lower Realized Risk HLF
Unified Institutional Score Composite Signal 39.8 / 100 (SELL) 35.2 / 100 (SELL) Higher Composite ABVE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABVE vs HLF Buy Guide
ABVE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live ABVE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
HLF SURGE
5d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live HLF Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABVE nor HLF registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.